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Introduction
The “DNA” has been unraveled by science as the science of 
life. Added to this, the contribution of science to the modern 
world is incredible. The howling discovery on the framework 
of DNA was brought up by Sir James Watson and Crick.[1] One 
such contribution by science is in the field of stem cell research. 
Although the concept of stem cell is just emerging, around 33 
BC, the regenerative potential was renowned when Aristotle 
first noted the ability of a lizard to grow back its tail from the 
lost tip.[1] Since continuous researches and attempts are made in 
understanding the regenerative capabilities of stem cell.
History
The term was coined by Russian histologist ALEXANDER 
MAXIMOW, in 1908, during a meeting held at the hematologic 
society in Berlin. In 1998, at the University of Wisconsin–Madison, 
the line “New Stem Cell Procedure Doesn’t Harm Embryos, 
Company Claims” was the introductory line proposed.[2]
What are stem cells?
Stem cells are specialized cells with an extraordinary capability to 
self-renew, differentiate into one or more specialized cell types, and 
play a crucial role in homeostasis and tissue repair. After an injury, 
stem cell undergoes cell division and produces one daughter cell 
and one progenitor cell. A progenitor cell is an intermediate cell 
that is formed before it undergoes full differentiation.[3]
Stem cell → Stem cell + Progenitor cell → Differentiated cell
Properties and Characteristics of Stem Cells
An ideal stem cell should possess the following two 
properties
1. Self-renewal: Ideally, a stem cell should have the capacity 
of self-renewal beyond the “HAYS LICK” limit (ability of 
the cell to proliferate to about 40–60 population doublings 
before its stage to achieve senescence).[4]
2. Potency: The property of differentiating into any type of 
cell.[5]
• Totipotency
• Pluripotency
• Multipotency
• Unipotency.
Harvesting and Isolation of Stem Cell in Dentistry
Sample selection criteria
• Deciduous teeth selected should be vital with two-third of 
root present and the tooth most preferred is the posterior 
freshly extracted teeth.
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• Adult teeth selected should be vital, without any infection 
or pathology and the preferred tooth should not be mobile 
because it lacks blood supply.[6]
Harvesting and isolation
Tooth selected for harvesting must be extracted in a sterile 
environment after complete examination of the tooth by the 
dental surgeon, with prior consent from the patient.
Guidelines for extraction
Before starting with the procedure, prophylactic antibiotic must 
be given 1 h before the procedure and antiseptic mouthwash just 
before the extraction. The skin around the site must be prepared 
with butadiene. Tooth should be carefully extracted avoiding 
fracture of the crown and then immediately transferred into the 
container.
Post-extraction protocol
The isolated tooth is gently washed in 70% of ethanol and 
then rinsed in phosphate-buffered saline containing antibiotics 
(100 IU/ml penicillin and 100 µg/ml streptomycin) to remove 
the ethanol. Then, the tooth is transferred to another tube where 
2 ml of tooth preservation cocktail is added and left for 5 min. To 
this, 1 ml of nourishment medium is added and the tube is sealed 
with paraffin film after labeling.[7]
Stem cell transport and storage
The tube is transferred to the laboratory within 48 h under room 
temperature. In the laboratory, the pulp is extirpated with barbed 
broaches or by cutting with diamond disc with coolant to avoid 
damage to the pulp. The isolated pulp is then trypsinized and 
cultured. Then, they are stored using fluorescence activated 
storing system and stored by either cryopreserving or magnetic 
freezing.[8]
Cryopreservation
It is the process of preservation of teeth for future use. The 
extracted teeth are cooled to a temperature as low as −196°C; 
rapid freezing is to be avoided to prevent ice formation and 
dehydration leading to cell demise. It has been concluded that 
stem cells can undergo long-term cryopreservation without 
losing the potency to self-renew and divide.[9]
Risk Factors of Stem Cell Therapy
• Tumor formation: Some stem cells are considered as 
potential candidates for malignant transformation.
• Immune response: Transported stem cells may affect the 
host immune response by modulating the immune system.
• Adventitious agents: Manufacturing of cell-based medicinal 
products inevitably does not include terminal sterilization, 
purification, viral removal, and inactivation. Therefore, viral 
and bacterial safety is a pivotal risk, where donor history is of 
utmost importance to avoid such risks.[10]
Stem Cells from the Oromaxillofacial Region
Stem cells from oral and maxillofacial region predominantly 
contain mesenchymal stem cells (MSCs) [Figure 1]. Different 
stem cells isolated are as follows:
1. Dental pulp stem cells (DPSCs)
2. Stem cells from human exfoliated deciduous teeth (SHED)
3. Periodontal ligament stem cells (PDLSCs)
4. Stem cells from apical papilla (SCAP)
5. Dental follicle progenitor cells (DFPCs).
DPSCs
These are the first tooth-derived mesenchymal type stem cells in 
2000. They are known to differentiate into osteoblast, smooth 
muscle cells, adipocyte-like cells, neuron, dentin, and dentin 
pulp-like complex.[11]
SHED
These are progenitor cells isolated from the pulp remnant of 
exfoliated deciduous teeth. They differentiate into osteoblast, 
odontoblast, adipocyte, and neural cells.
PDLSCs
They are known to be of neural crest cell origin, PDLSCs 
residing in the perivascular wall have common properties in cell 
morphology, phenotype, and differentiation potentials. They 
differentiate into osteoblast, cementoblasts, adipocytes, and 
chondrocyte.[12]
SCAPs
These cells are isolated from the root apex of developing tooth, 
which aid in root formation. They differentiate into osteoblast, 
adipocyte, chondrocyte, and neuron under appropriate 
conditions.[13]
DFPCs
During the early tooth formation stages, these cells are harvested 
from the dental follicle. They are known to differentiate into 
osteoblast, adipocyte, and chondrocytes.
Clinical Application in Oral and Maxillofacial Region
Enamel, dentin, dental pulp, cementum, periodontal ligament, 
craniofacial bones, skin, subcutaneous soft tissue, and salivary 
glands, these are the structures of interest in oral maxillofacial 
region.
In response to a tissue injury, the dental pulp has the potency 
and capacity to regenerate tubular dentin which was observed 
when scaffolds were implanted in immunocompromised mice in 
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a clinical trial. Regeneration of dental pulp marks the basic clinical 
application in the field of regenerative dentistry.[14] Bone marrow 
stem cells prove to be a promising tool in the regeneration of 
periodontal ligament and other supporting structures. Based on 
various clinical trials, it was proved that bone marrow stem cells 
can be used as an alternative choice in the treatment of periodontal 
diseases.[15] Stem cells are also helpful in the regeneration of 
bone and correction of various craniofacial defects. Following 
a trauma, fracture of bones and soft tissue injury occur. In such 
cases of the reconstruction of soft tissues and cranial bones are 
of paramount importance where stem cells can be used as an 
effective tool.[16] For soft tissue construction, adipose tissue with 
proper scaffold has been used in researches.[17]
Radiation-induced Maxillofacial Complication
The most common disease faced by the maxillofacial clinician 
is osteonecrosis after craniofacial radiation, osteomyelitis, and 
bisphosphonates related necrosis of the jaw (BRONJ). The most 
commonly accepted and explained theory for the development 
of the conditions are tissue hypoxia, radiation-induced 
hypovascularity, and hypocellularity.[18] Numerous treatment 
modalities have been put forward. Very recently, proposed 
treatment modality is based on the regenerative capacity of stem 
cells. In a clinical trial, Kikuiri et al. infused MSCs in mice with 
BRONJ, where they observed that the stem cells modulated 
the immune system, prevented, and cured the disease.[19] This 
is mainly due to the capability of stem cells in inducing ectopic 
bone formation and angiogenesis.[20]
Radiation-induced salivary gland damage is mainly due 
to irreversible damage to muscarinic receptors and reduced 
parasympathetic nervous function, leading to post-radiation 
effects. This can be overcome with new modalities such as 
follows:
• Isolation of autologous epithelial stem cell/progenitor cell 
before radiation therapy which can be cryoprecipitated and 
transplanted into the gland after post-radiation.
• Transplanting bioengineered salivary gland tissue into the gland 
space using cells cultured with biomaterials or growth factors.[21]
Stem Cells in the Treatment of Autoimmune Diseases
Autoimmune diseases occur when the body tissues are 
damaged by the host immune system. Various treatment 
modalities such as anti-inflammatory, immunosuppressive, and 
immunomodulatory agents are used which have proved with 
satisfying results in most cases. In the early 1990s, autologous 
hematopoietic stem cells were used in the treatment of 
autoimmune diseases.[22] Later another cell-based therapy, 
the MSCs were used as an anti-inflammatory and tissue 
protecting agent. The advantage is that the patient need not 
be immunosuppressed before MSC transplantation, as the 
therapeutic effect is considered to be delivered in the inflamed 
organ due to homing of MSC in the involve inflamed organ 
exhibiting a relatively short-lived effect.[23] On the contrary, 
adipose tissue-derived MSCs are emerging as an alternative 
source of MSC as adipose tissue is abundant, easily obtained, and 
accessible, with little patient discomfort.[24]
Role of Stem Cells in Oral Mucosal Lesions
Stem cell therapy if focused in the treatment of certain lesions 
only. They are as follows:
• Ulcerative lesions
• Premalignant disorders
• Malignant lesion.
In oral ulcers, bone marrow-derived MSCs are used as they 
have the ability to differentiate into adipocytes, osteoblast, 
and chondrocytes. They also possess the ability to engraft at 
the site of tissue injury and promote wound healing through 
downregulation of pro-inflammatory mediators and by increased 
production of soluble factors.[25]
In oral submucous fibrosis, stem cell therapy is primarily 
aimed at neoangiogenesis. They stimulate the resident stem 
cells to form new fibroblast, thus removing the disintegrated 
biochemically and morphologically altering the collagen 
fibers.[26]
In oral carcinomas, the role of stem cells is remarkable and 
proves to be a possible new treatment options in the future. 
They are used based on their property to regenerate and their 
use in cancer therapy as delivery vehicles. These stem cells act 
as delivery vehicles as the tumor send out chemoattractants to 
recruit MSC to form stroma of the tumor.[27]
Conclusion
Remedy in the field of medicine is mainly due to emerging 
interest of humankind to replicate and duplicate nature. Various 
treatment modalities have been put forward and practiced in our 
day-to-day life to alleviate pain and suffering of man diseases. 
The ability to treat incurable diseases is now challenged by 
Figure 1: Stem cells from oral and maxillofacial region[9]
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the evolution of stem cell therapy. Further, more advances 
and researches are needed for simple, definitive, and effective 
treatment of various oral and maxillofacial diseases.
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